RALS-TGCM

Web-based Graphic Reports for Patients
on Glycemic Control Protocols

"The wide range of graphic reports available in RALS-TGCM are critical to the success of our Tight Glycemic Control program."

Herald Walden, MT(ASCP), Point of Care Testing Coordinator
Florida Hospital, Orlando, FL

Implementing a Tight Glycemic Control Protocol is One Thing...
Managing it is Quite Another.

 

Are your nurses asking for more blood glucose meters? Do you see your blood glucose strip usage increasing?

 

If you answered yes to either of these questions, you're not alone. Recent clinical research suggests that patients whose blood glucose levels are controlled within defined ranges suffer fewer infections and other complications^1,2.  This information is leading hospitals to implement tight glycemic control protocols, which means more frequent point-of-care blood glucose testing.

 

Click here for a sample of TGCM reports...

 

Tight glycemic control may be beginning in your hospital and may be used to treat at least one out of every four patients³. But with increased testing comes increased data that needs to be managed and measured.

 

RALS®-TGCM provides the data management you need to measure program success!

 

RALS-TGCM is a new tool to help manage your glucose data.  Designed for clinicians it provides aggregate data management reports via a web interface as well as offering valuable feedback relative to glycemic control protocols at the patient level. See Nearing High Tide on Low Blood Sugars.

 

To contact your MAS representative for a demonstration and pricing click here.

---

Tight Glucose Control Cuts Heart Disease by one half in People with Type 1 Diabetes Intensive glucose control lowers the risk of heart disease and stroke by about 50 percent in people with type 1 diabetes, researchers report in the December 22, 2005, issue of the New England Journal of Medicine. Their findings are based on a follow-up study of patients who took part more than a decade ago in the Diabetes Control and Complications Trial (DCCT), a major study funded by the National Institutes of Health (NIH). Click here for more >

---

 

1. http://www.aace.com/newsroom/press/2006/index.php?r=20060201

2. Van den Berghe G, Wouters P, Weekers F, Verwaest C, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med. 2001
Nov 8;345(19):1359-67.

3. Furnary AP, Gao G, Grunkemeier GL, Wu Y, et al. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2003 May;125(5):1007-21.